Dr. Hossein Ameri, MD
Ophthalmology (Ophthalmology Physician)
1450 San Pablo St, Usc Roski Eye Institute
Los Angeles, CA 90033
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 33
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 368
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
CA license A34789 · TX license 0034789
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Keck Hospital of Usc Los Angeles, CA
- Los Angeles General Medical Center Los Angeles, CA
Medical groups
- Usc Care Medical Group Inc (1,380 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 368
- Services billed
- 5,507
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Imaging of retina | 829 | 377 |
| Established patient complete exam of visual system | 735 | 333 |
| Injection of drug into eye | 319 | 78 |
| Injection, aflibercept, 1 mg | 184 | 20 |
| Injection, bevacizumab, 10 mg | 59 | 17 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 36 | 31 |
| Established patient office or other outpatient visit, 30-39 minutes | 20 | 17 |
| New patient office or other outpatient visit, 60-74 minutes | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Los Angeles, CA | 44 |
| Cyclosporine Other prescribers in Los Angeles, CA | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 2 payments worth $116 in total to this clinician.
| Alcon Vision LLC | $116 |
|---|
| Food and Beverage | $116 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $500 in research payments for these studies, mostly to the institutions running them.
- Global Patient Registry of Inherited Retinal Diseases (EYERD Registry)
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.